Literature DB >> 22643189

Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.

Evelien A N Oostdijk1, Anne Marie G A de Smet, Jozef Kesecioglu, Marc J M Bonten.   

Abstract

OBJECTIVES: Prevalences of cephalosporin-resistant Enterobacteriaceae are increasing globally, especially in intensive care units (ICUs). The effect of selective digestive tract decontamination (SDD) on the eradication of cephalosporin-resistant Enterobacteriaceae from the intestinal tract is unknown. We quantified eradication rates of cephalosporin-resistant and cephalosporin-susceptible Enterobacteriaceae during SDD in patients participating in a 13 centre cluster-randomized study and from a single-centre cohort.
METHODS: All SDD patients colonized with Enterobacteriaceae in the intestinal tract at ICU admission were included. Cephalosporin resistance was defined as resistance to ceftazidime, cefotaxime or ceftriaxone and aminoglycoside resistance as resistance to tobramycin or gentamicin. Duration of rectal colonization was determined by screening twice weekly during ICU stay. Swabs were inoculated on selective medium supplemented with tobramycin or cefotaxime.
RESULTS: Five hundred and seven (17%) of 2959 SDD patients with at least one rectal sample were colonized with Enterobacteriaceae at ICU admission: 77 (15%) with cephalosporin-resistant Enterobacteriaceae and 50 (10%) with aminoglycoside-resistant Enterobacteriaceae. Fifty-six (73%) patients colonized with cephalosporin-resistant Enterobacteriaceae were successfully decontaminated before ICU discharge, as were 343 (80%) patients colonized with cephalosporin-susceptible Enterobacteriaceae (P = 0.17). For aminoglycoside resistance, 31 (62%) patients were decontaminated, as were 368 patients (81%) colonized with aminoglycoside-susceptible Enterobacteriaceae (P < 0.01). On average, decolonization was demonstrated after 4 days if colonized with cephalosporin-susceptible Enterobacteriaceae and aminoglycoside-susceptible Enterobacteriaceae, and after 5 and 5.5 days if colonized with cephalosporin-resistant Enterobacteriaceae and aminoglycoside-resistant Enterobacteriaceae, respectively (log-rank test P = 0.053 for cephalosporin resistance and P = 0.03 for aminoglycoside resistance). If eradication failed, no associations were found with increased resistance in time (P > 0.05 for all comparisons).
CONCLUSIONS: SDD can successfully eradicate cephalosporin-resistant Enterobacteriaceae from the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22643189     DOI: 10.1093/jac/dks187

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

1.  For control of colonisation with extended-spectrum β-lactamase-producing bacteria, SDD does work.

Authors:  Durk Zandstra; Francisco Abecasis; Nia Taylor; Vladimir Damjanovic; Luciano Silvestri; H K F van Saene
Journal:  Intensive Care Med       Date:  2013-01-04       Impact factor: 17.440

2.  Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.

Authors:  L A Denkel; P Gastmeier; R Leistner
Journal:  Infection       Date:  2014-08-27       Impact factor: 3.553

3.  Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.

Authors:  Matthew P Kronman; Danielle M Zerr; Xuan Qin; Janet Englund; Cathy Cornell; Jean E Sanders; Jeffrey Myers; Jaipreet Rayar; Jessica E Berry; Amanda L Adler; Scott J Weissman
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-21       Impact factor: 2.803

4.  Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Qin Liu; Tao Zuo; Wenqi Lu; Yun Kit Yeoh; Qi Su; Zhilu Xu; Whitney Tang; Keli Yang; Fen Zhang; Louis H S Lau; Rashid N S Lui; Miu Ling Chin; Rity Wong; Chun Pan Cheung; Wenyi Zhu; Paul K S Chan; Francis K L Chan; Grace C Lui; Siew C Ng
Journal:  mSystems       Date:  2022-06-01       Impact factor: 7.324

5.  Pilot Study of the Pharmacokinetics of Cefotaxime in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy.

Authors:  Joost B Koedijk; Corinne G H Valk-Swinkels; Tom A Rijpstra; Daan J Touw; Paul G H Mulder; Peter H J van der Voort; Nils E van 't Veer; Nardo J M van der Meer
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.

Authors:  Srinivasa Nithin Gopalsamy; Michael H Woodworth; Tiffany Wang; Cynthia T Carpentieri; Nirja Mehta; Rachel J Friedman-Moraco; Aneesh K Mehta; Christian P Larsen; Colleen S Kraft
Journal:  Am J Med Sci       Date:  2018-08-29       Impact factor: 2.378

Review 7.  Selective decontamination and antibiotic resistance in ICUs.

Authors:  Nienke L Plantinga; Marc J M Bonten
Journal:  Crit Care       Date:  2015-06-24       Impact factor: 9.097

8.  Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.

Authors:  Etienne Ruppé; Antoine Andremont
Journal:  Front Microbiol       Date:  2013-05-28       Impact factor: 5.640

9.  The gut is the epicentre of antibiotic resistance.

Authors:  Jean Carlet
Journal:  Antimicrob Resist Infect Control       Date:  2012-11-27       Impact factor: 4.887

10.  Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis.

Authors:  Evelien A N Oostdijk; G A de Wit; Marina Bakker; Anne Marie G A de Smet; M J M Bonten
Journal:  BMJ Open       Date:  2013-03-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.